drugset / Trial / NCT00451984
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
RandomizedSingle-groupOpen-labelPrevention
Summary
The response to vaccination for hepatitis is reduced in patients with HIV infection. The hypothesis of the study is that adjuvant interleukin-2 administered subcutaneously at the time of vaccination improves the response rate.
Timeline
- Start
- 2007-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Twinrix | Vaccine | — | — |
| Subject | aldesleukin | Protein / enzyme biologic | — | Subcutaneous |